Indofarma Tbk Cash Flow Conversion Efficiency

Latest as of March 2025: 0.024x

Indofarma Tbk cash flow conversion efficiency. Based on the latest financial reports, Indofarma Tbk (INAF) has a cash flow conversion efficiency ratio of 0.024x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-18.71 Billion ≈ $-1.10 Million USD) by net assets (Rp-788.96 Billion ≈ $-46.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Indofarma Tbk (2000–2024)

Cash flow conversion efficiency of Indofarma Tbk from 2000 to 2024. This chart illustrates how Indofarma Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Indofarma Tbk share price for real-time trading data and today's change.

Indofarma Tbk Cash Flow Conversion Ratio Explained

Indofarma Tbk cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Indofarma Tbk Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Indofarma Tbk ranked by their cash flow conversion efficiency. Also see market cap of Indofarma Tbk for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Pulsenmore Ltd TA:PULS	-0.196x
Independence Gold Corp V:IGO	-0.056x
VenHub Global, Inc. NASDAQ:VHUB	68.721x
SD SYSTEM Co. Ltd KQ:121890	-0.098x
ZICOM Group Ltd AU:ZGL	0.499x
Asia Economy Daily Co Ltd KQ:127710	0.065x
Mistral Iberia Real Estate SOCIMI S.A. MC:YMIB	-0.026x
Desane Group Holdings Ltd AU:DGH	0.000x

Annual Cash Flow Conversion Efficiency for Indofarma Tbk (2000–2024)

The table below shows the annual cash flow conversion efficiency of Indofarma Tbk from 2000 to 2024. Review free cash flow generation of Indofarma Tbk to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Rp-1.14 Trillion ≈ $-67.04 Million	Rp-21.65 Billion ≈ $-1.27 Million	0.019x	-91.99%
2023-12-31	Rp-804.15 Billion ≈ $-47.12 Million	Rp-190.10 Billion ≈ $-11.14 Million	0.236x	+126.88%
2022-12-31	Rp86.35 Billion ≈ $5.06 Million	Rp-75.95 Billion ≈ $-4.45 Million	-0.880x	-581.24%
2021-12-31	Rp508.31 Billion ≈ $29.78 Million	Rp92.90 Billion ≈ $5.44 Million	0.183x	+68.96%
2020-12-31	Rp430.33 Billion ≈ $25.22 Million	Rp46.55 Billion ≈ $2.73 Million	0.108x	+162.70%
2019-12-31	Rp504.94 Billion ≈ $29.59 Million	Rp20.79 Billion ≈ $1.22 Million	0.041x	+129.05%
2018-12-31	Rp496.65 Billion ≈ $29.10 Million	Rp-70.39 Billion ≈ $-4.12 Million	-0.142x	-150.69%
2017-12-31	Rp526.41 Billion ≈ $30.85 Million	Rp147.18 Billion ≈ $8.62 Million	0.280x	+150.63%
2016-12-31	Rp575.76 Billion ≈ $33.74 Million	Rp-317.96 Billion ≈ $-18.63 Million	-0.552x	-343.75%
2015-12-31	Rp592.71 Billion ≈ $34.73 Million	Rp134.28 Billion ≈ $7.87 Million	0.227x	-9.82%
2014-12-31	Rp591.96 Billion ≈ $34.69 Million	Rp148.73 Billion ≈ $8.71 Million	0.251x	+204.81%
2013-12-31	Rp590.79 Billion ≈ $34.62 Million	Rp-141.62 Billion ≈ $-8.30 Million	-0.240x	-280.88%
2012-12-31	Rp650.10 Billion ≈ $38.09 Million	Rp-40.91 Billion ≈ $-2.40 Million	-0.063x	-230.42%
2011-12-31	Rp609.19 Billion ≈ $35.70 Million	Rp29.40 Billion ≈ $1.72 Million	0.048x	-36.66%
2010-12-31	Rp311.27 Billion ≈ $18.24 Million	Rp23.71 Billion ≈ $1.39 Million	0.076x	-43.89%
2009-12-31	Rp298.72 Billion ≈ $17.50 Million	Rp40.56 Billion ≈ $2.38 Million	0.136x	+121.50%
2008-12-31	Rp296.60 Billion ≈ $17.38 Million	Rp-187.31 Billion ≈ $-10.98 Million	-0.632x	-320.73%
2007-12-31	Rp291.56 Billion ≈ $17.08 Million	Rp83.42 Billion ≈ $4.89 Million	0.286x	+9.70%
2006-12-31	Rp280.49 Billion ≈ $16.44 Million	Rp73.15 Billion ≈ $4.29 Million	0.261x	+226.07%
2005-12-31	Rp265.25 Billion ≈ $15.54 Million	Rp-54.87 Billion ≈ $-3.22 Million	-0.207x	-133.21%
2004-12-31	Rp255.67 Billion ≈ $14.98 Million	Rp159.25 Billion ≈ $9.33 Million	0.623x	+310.06%
2003-12-31	Rp267.94 Billion ≈ $15.70 Million	Rp40.70 Billion ≈ $2.39 Million	0.152x	+64.33%
2000-12-31	Rp292.57 Billion ≈ $17.14 Million	Rp27.05 Billion ≈ $1.58 Million	0.092x	--

About Indofarma Tbk

JK:INAF Indonesia Drug Manufacturers - Specialty & Generic

Market Cap

$22.88 Million

Rp390.51 Billion IDR

Market Cap Rank

#24516 Global

#498 in Indonesia

Share Price

Rp126.00

Change (1 day)

+0.00%

52-Week Range

Rp126.00 - Rp126.00

All Time High

Rp6975.00